Boreal Genomics

About:

Boreal develops research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma.

Website: http://borealgenomics.com

Twitter/X: borealgenomics

Top Investors: In-Q-Tel, ARCH Venture Partners, PenderFund Capital Management, Kearny Venture Partners, GrowthWorks Capital

Description:

Boreal is committed to improving cancer patient care through the development of research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma. It also provides novel DNA enrichment and library construction solutions for high accuracy sequencing in liquid biopsy applications. The company's OnTarget platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. The OnTarget assay is available as a research-use service to reveal tumor mutations that are undetectable with other methods and may help guide selection of therapy, improve clinical trial efficiency, and accelerate drug development programs. Boreal Genomics was founded in 2007 and is based in Vancouver, BC, Canada.